BPH Global Ltd
BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company's products include raw bird's nest and processed bird's nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics… Read more
BPH Global Ltd (BP8) - Net Assets
Latest net assets as of June 2025: AU$-1.46 Million AUD
Based on the latest financial reports, BPH Global Ltd (BP8) has net assets worth AU$-1.46 Million AUD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$541.00K) and total liabilities (AU$2.01 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$-1.46 Million |
| % of Total Assets | -270.69% |
| Annual Growth Rate | N/A |
| 5-Year Change | -122.61% |
| 10-Year Change | -135.25% |
| Growth Volatility | 638.47 |
BPH Global Ltd - Net Assets Trend (1999–2025)
This chart illustrates how BPH Global Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for BPH Global Ltd (1999–2025)
The table below shows the annual net assets of BPH Global Ltd from 1999 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$-1.46 Million | -14.93% |
| 2024-06-30 | AU$-1.27 Million | -239.73% |
| 2023-06-30 | AU$911.90K | -80.68% |
| 2022-06-30 | AU$4.72 Million | -27.12% |
| 2021-06-30 | AU$6.48 Million | +752.18% |
| 2020-06-30 | AU$760.03K | -63.49% |
| 2019-06-30 | AU$2.08 Million | +73.36% |
| 2018-06-30 | AU$1.20 Million | -43.48% |
| 2017-06-30 | AU$2.12 Million | -48.87% |
| 2016-06-30 | AU$4.15 Million | +2672.57% |
| 2015-06-30 | AU$149.84K | +100.20% |
| 2014-06-30 | AU$-76.25 Million | -212.18% |
| 2007-06-30 | AU$67.97 Million | +0.72% |
| 2006-06-30 | AU$67.48 Million | +10.35% |
| 2005-06-30 | AU$61.15 Million | +240.71% |
| 2004-06-30 | AU$17.95 Million | +42.04% |
| 2003-06-30 | AU$12.64 Million | +9.38% |
| 2002-06-30 | AU$11.55 Million | +2.33% |
| 2001-06-30 | AU$11.29 Million | +117.46% |
| 2000-06-30 | AU$5.19 Million | -7.73% |
| 1999-06-30 | AU$5.63 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to BPH Global Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6660768600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$80.20 Million | % |
| Other Comprehensive Income | AU$1.80 Million | % |
| Total Equity | AU$-1.45 Million | 100.00% |
BPH Global Ltd Competitors by Market Cap
The table below lists competitors of BPH Global Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Grupo Vasconia S.A.B
MX:VASCONI
|
$781.57K |
|
American Pwr Group
PINK:APGI
|
$782.54K |
|
Planet Properindo Jaya Pt
JK:PLAN
|
$783.55K |
|
REALITES EO 653
F:2ZQ
|
$783.98K |
|
BEYOND AIR INC. DL-0001
F:48L
|
$781.06K |
|
Uma Exports Limited
NSE:UMAEXPORTS
|
$780.88K |
|
Recreatives Industries Inc.
PINK:RECX
|
$780.78K |
|
Educomp Solutions Limited
NSE:EDUCOMP
|
$780.57K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BPH Global Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -966,819 to -1,450,339, a change of -483,520.
- Net loss of 1,486,553 reduced equity.
- Other comprehensive income decreased equity by 118,361.
- Other factors increased equity by 1,121,394.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-1.49 Million | -102.5% |
| Other Comprehensive Income | AU$-118.36K | -8.16% |
| Other Changes | AU$1.12 Million | +77.32% |
| Total Change | AU$- | % |
Book Value vs Market Value Analysis
This analysis compares BPH Global Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1999-06-30 | AU$28.70 | AU$0.00 | x |
| 2000-06-30 | AU$100.55 | AU$0.00 | x |
| 2001-06-30 | AU$37.47 | AU$0.00 | x |
| 2002-06-30 | AU$28.46 | AU$0.00 | x |
| 2003-06-30 | AU$27.61 | AU$0.00 | x |
| 2004-06-30 | AU$31.98 | AU$0.00 | x |
| 2005-06-30 | AU$16.08 | AU$0.00 | x |
| 2006-06-30 | AU$5.57 | AU$0.00 | x |
| 2007-06-30 | AU$15.13 | AU$0.00 | x |
| 2014-06-30 | AU$-40.83 | AU$0.00 | x |
| 2015-06-30 | AU$0.00 | AU$0.00 | x |
| 2016-06-30 | AU$0.01 | AU$0.00 | x |
| 2017-06-30 | AU$0.01 | AU$0.00 | x |
| 2018-06-30 | AU$0.00 | AU$0.00 | x |
| 2019-06-30 | AU$0.00 | AU$0.00 | x |
| 2020-06-30 | AU$0.00 | AU$0.00 | x |
| 2021-06-30 | AU$0.01 | AU$0.00 | x |
| 2022-06-30 | AU$0.00 | AU$0.00 | x |
| 2023-06-30 | AU$0.00 | AU$0.00 | x |
| 2024-06-30 | AU$0.00 | AU$0.00 | x |
| 2025-06-30 | AU$0.00 | AU$0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BPH Global Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -421.87%
- • Asset Turnover: 0.65x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (2354.39%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1999 | -0.07% | 0.00% | 0.00x | 2.14x | AU$-566.78K |
| 2000 | 5.27% | 33.40% | 0.06x | 2.52x | AU$-245.63K |
| 2001 | -0.86% | -0.76% | 0.72x | 1.56x | AU$-1.23 Million |
| 2002 | 2.22% | 2.66% | 0.55x | 1.53x | AU$-899.19K |
| 2003 | 8.57% | 0.85% | 3.36x | 2.99x | AU$-180.18K |
| 2004 | 12.98% | 0.74% | 3.89x | 4.48x | AU$534.73K |
| 2005 | -10.63% | -0.48% | 3.46x | 6.43x | AU$-4.43 Million |
| 2006 | -151.45% | -1.83% | 3.74x | 22.18x | AU$-14.99 Million |
| 2007 | -11.28% | -0.28% | 3.61x | 11.12x | AU$-5.37 Million |
| 2015 | 50079.24% | 1098700.44% | 0.00x | 23.90x | AU$75.03 Million |
| 2016 | -857.33% | -47648.07% | 0.02x | 1.17x | AU$-36.03 Million |
| 2017 | -170.94% | -11483.85% | 0.01x | 1.24x | AU$-3.84 Million |
| 2018 | -279.29% | -1153.64% | 0.18x | 1.32x | AU$-3.47 Million |
| 2019 | -209.51% | -226.59% | 0.64x | 1.44x | AU$-3.71 Million |
| 2020 | -341.80% | -216.32% | 0.72x | 2.19x | AU$-1.63 Million |
| 2021 | -56.50% | -36.88% | 0.92x | 1.66x | AU$-3.69 Million |
| 2022 | -116.21% | -24.65% | 1.88x | 2.50x | AU$-3.84 Million |
| 2023 | -814.51% | -1273736.87% | 0.00x | 3.97x | AU$-4.37 Million |
| 2024 | 0.00% | -2065.73% | 0.16x | 0.00x | AU$-2.17 Million |
| 2025 | 0.00% | -421.87% | 0.65x | 0.00x | AU$-1.34 Million |
Industry Comparison
This section compares BPH Global Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $21,557,120
- Average return on equity (ROE) among peers: -166.14%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BPH Global Ltd (BP8) | AU$-1.46 Million | -0.07% | N/A | $781.31K |
| Aft Pharmaceuticals Ltd (AFP) | $28.23 Million | -47.00% | 1.31x | $53.97 Million |
| Althea Group Holdings Ltd (AGH) | $42.70 Million | -35.24% | 0.26x | $6.03 Million |
| BOD Science Ltd (BOD) | $3.47 Million | -155.95% | 0.53x | $1.38 Million |
| Cann Group Ltd (CAN) | $-2.77 Million | 0.00% | 0.00x | $2.39 Million |
| ECS Botanics Holdings Ltd (ECS) | $188.48K | -116.04% | 0.13x | $2.73 Million |
| IDT Australia Ltd (IDT) | $25.01 Million | -24.32% | 0.25x | $8.48 Million |
| Invion Ltd (IVX) | $19.58 Million | -11.45% | 0.02x | $2.48 Million |
| Little Green Pharma Ltd (LGP) | $77.26 Million | -10.55% | 0.12x | $14.26 Million |
| Live Verdure Ltd (LV1) | $362.12K | -1094.69% | 2.55x | $28.27 Million |